These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 32791124)

  • 1. Vaginal estrogen therapy is associated with increased Lactobacillus in the urine of postmenopausal women with overactive bladder symptoms.
    Thomas-White K; Taege S; Limeira R; Brincat C; Joyce C; Hilt EE; Mac-Daniel L; Radek KA; Brubaker L; Mueller ER; Wolfe AJ
    Am J Obstet Gynecol; 2020 Nov; 223(5):727.e1-727.e11. PubMed ID: 32791124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder bacterial diversity differs in continent and incontinent women: a cross-sectional study.
    Price TK; Lin H; Gao X; Thomas-White KJ; Hilt EE; Mueller ER; Wolfe AJ; Dong Q; Brubaker L
    Am J Obstet Gynecol; 2020 Nov; 223(5):729.e1-729.e10. PubMed ID: 32380174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary microbiome community types associated with urinary incontinence severity in women.
    Carnes MU; Siddiqui NY; Karstens L; Gantz MG; Dinwiddie DL; Sung VW; Bradley M; Brubaker L; Ferrando CA; Mazloomdoost D; Richter HE; Rogers RG; Smith AL; Komesu YM;
    Am J Obstet Gynecol; 2024 Mar; 230(3):344.e1-344.e20. PubMed ID: 38937257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of preoperative intravaginal estrogen on pelvic floor disorder symptoms in postmenopausal women with pelvic organ prolapse.
    Rahn DD; Richter HE; Sung VW; Hynan LS; Pruszynski JE
    Am J Obstet Gynecol; 2023 Sep; 229(3):309.e1-309.e10. PubMed ID: 37244454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
    Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ
    Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the relationship between vaginal and urinary microbiomes.
    Komesu YM; Dinwiddie DL; Richter HE; Lukacz ES; Sung VW; Siddiqui NY; Zyczynski HM; Ridgeway B; Rogers RG; Arya LA; Mazloomdoost D; Levy J; Carper B; Gantz MG;
    Am J Obstet Gynecol; 2020 Feb; 222(2):154.e1-154.e10. PubMed ID: 31421123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The concomitant use of fesoterodine and topical vaginal estrogen in the management of overactive bladder and sexual dysfunction in postmenopausal women.
    Chughtai B; Forde JC; Buck J; Asfaw T; Lee R; Te AE; Kaplan SA
    Post Reprod Health; 2016 Mar; 22(1):34-40. PubMed ID: 26883688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Vaginal Pelvic Floor Electrical Stimulation (PFS) and Local Vaginal Estrogen for Treatment of Overactive Bladder (OAB) in Perimenopausal Females. Randomized Controlled Trial (RCT).
    Abdelbary AM; El-Dessoukey AA; Massoud AM; Moussa AS; Zayed AS; Elsheikh MG; Ghoneima W; Abdella R; Yousef M
    Urology; 2015 Sep; 86(3):482-6. PubMed ID: 26135813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Local Estrogen on the Urogenital Microbiome in Genitourinary Syndrome of Menopause: A Randomized-Controlled Trial.
    Lillemon JN; Karstens L; Nardos R; Garg B; Boniface ER; Gregory WT
    Female Pelvic Med Reconstr Surg; 2022 Jun; 28(6):e157-e162. PubMed ID: 35420551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incontinence medication response relates to the female urinary microbiota.
    Thomas-White KJ; Hilt EE; Fok C; Pearce MM; Mueller ER; Kliethermes S; Jacobs K; Zilliox MJ; Brincat C; Price TK; Kuffel G; Schreckenberger P; Gai X; Brubaker L; Wolfe AJ
    Int Urogynecol J; 2016 May; 27(5):723-33. PubMed ID: 26423260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Tolterodine and Vaginal Estradiol Cream for Overactive Bladder Symptoms After Randomized Single-Therapy Treatment.
    Ellington DR; Szychowski JM; Malek JM; Gerten KA; Burgio KL; Richter HE
    Female Pelvic Med Reconstr Surg; 2016; 22(4):254-60. PubMed ID: 26945271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network-Based Differences in the Vaginal and Bladder Microbial Communities Between Women With and Without Urgency Urinary Incontinence.
    Nardos R; Leung ET; Dahl EM; Davin S; Asquith M; Gregory WT; Karstens L
    Front Cell Infect Microbiol; 2022; 12():759156. PubMed ID: 35402312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the urogenital microbiome and surgical treatment response in women undergoing midurethral sling operation for mixed urinary incontinence.
    Richter HE; Carnes MU; Komesu YM; Lukacz ES; Arya L; Bradley M; Rogers RG; Sung VW; Siddiqui NY; Carper B; Mazloomdoost D; Dinwiddie D; Gantz MG;
    Am J Obstet Gynecol; 2022 Jan; 226(1):93.e1-93.e15. PubMed ID: 34297969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence.
    Pearce MM; Hilt EE; Rosenfeld AB; Zilliox MJ; Thomas-White K; Fok C; Kliethermes S; Schreckenberger PC; Brubaker L; Gai X; Wolfe AJ
    mBio; 2014 Jul; 5(4):e01283-14. PubMed ID: 25006228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between bladder microbiota and overactive bladder symptom severity: a cross-sectional study.
    Li K; Chen C; Zeng J; Wen Y; Chen W; Zhao J; Wu P
    BMC Urol; 2022 Mar; 22(1):39. PubMed ID: 35305613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary microbes and postoperative urinary tract infection risk in urogynecologic surgical patients.
    Thomas-White KJ; Gao X; Lin H; Fok CS; Ghanayem K; Mueller ER; Dong Q; Brubaker L; Wolfe AJ
    Int Urogynecol J; 2018 Dec; 29(12):1797-1805. PubMed ID: 30267143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause?
    Matarazzo MG; Caruso S; Giunta G; Valenti G; Sarpietro G; Cianci A
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():75-79. PubMed ID: 29367168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Child's urine is not sterile: A pilot study evaluating the Pediatric Urinary Microbiome.
    Storm DW; Copp HL; Halverson TM; Du J; Juhr D; Wolfe AJ
    J Pediatr Urol; 2022 Jun; 18(3):383-392. PubMed ID: 35337731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the urinary microbiota of women with uncomplicated stress urinary incontinence.
    Thomas-White KJ; Kliethermes S; Rickey L; Lukacz ES; Richter HE; Moalli P; Zimmern P; Norton P; Kusek JW; Wolfe AJ; Brubaker L;
    Am J Obstet Gynecol; 2017 Jan; 216(1):55.e1-55.e16. PubMed ID: 27498309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.